Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

SELL
$18.01 - $23.78 $50,031 - $66,060
-2,778 Reduced 47.37%
3,087 $66,000
Q3 2022

Nov 04, 2022

BUY
$16.32 - $26.37 $2,790 - $4,509
171 Added 3.0%
5,865 $113,000
Q2 2022

Aug 03, 2022

BUY
$18.54 - $37.29 $105,566 - $212,329
5,694 New
5,694 $113,000
Q1 2022

May 02, 2022

SELL
$23.94 - $33.74 $26,932 - $37,957
-1,125 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$21.19 - $31.29 $6,145 - $9,074
290 Added 34.73%
1,125 $26,000
Q2 2021

Aug 12, 2021

SELL
$28.9 - $36.87 $69,331 - $88,451
-2,399 Reduced 74.18%
835 $29,000
Q1 2021

Apr 26, 2021

BUY
$32.03 - $42.85 $85,648 - $114,580
2,674 Added 477.5%
3,234 $113,000
Q4 2020

Feb 02, 2021

SELL
$31.56 - $42.16 $851,583 - $1.14 Million
-26,983 Reduced 97.97%
560 $21,000
Q3 2020

Oct 14, 2020

BUY
$23.19 - $41.61 $467,974 - $839,689
20,180 Added 274.07%
27,543 $919,000
Q2 2020

Jul 13, 2020

BUY
$14.82 - $29.92 $31,092 - $62,772
2,098 Added 39.85%
7,363 $195,000
Q1 2020

Apr 29, 2020

BUY
$11.67 - $27.23 $58,711 - $136,994
5,031 Added 2150.0%
5,265 $86,000
Q4 2019

Feb 05, 2020

SELL
$16.92 - $28.96 $41,995 - $71,878
-2,482 Reduced 91.38%
234 $5,000
Q3 2019

Oct 15, 2019

BUY
$20.0 - $31.88 $54,320 - $86,586
2,716 New
2,716 $54,000
Q2 2019

Jul 26, 2019

SELL
$30.67 - $37.86 $13,402 - $16,544
-437 Closed
0 $0
Q1 2019

Apr 18, 2019

SELL
$22.22 - $32.21 $3,421 - $4,960
-154 Reduced 26.06%
437 $0
Q4 2018

Jan 16, 2019

BUY
$20.9 - $32.57 $12,351 - $19,248
591 New
591 $14,000

Others Institutions Holding ALBO

About ALBIREO PHARMA, INC.


  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.